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Novel Cul3 binding proteins function to remodel
E3 ligase complexes
Wananit Wimuttisuk2,4, Mark West1, Brittney Davidge1, Kebing Yu3, Arthur Salomon2 and Jeffrey D Singer1*
Abstract
Background: Cullins belong to a family of scaffold proteins that assemble multi-subunit ubiquitin ligase complexes
to recruit protein substrates for ubiquitination via unique sets of substrate adaptor, such as Skp1 or Elongin B, and a
substrate-binding protein with a conserved protein-protein interacting domain, such as leucine-rich repeats (LRR), a
WD40 domain, or a zinc-finger domain. In the case of the Cullin3 (Cul3), it forms a BTB-Cul3-Rbx1 (BCR) ubiquitin
ligase complex where it is believed that a BTB domain-containing protein performs dual functions where it serves
as both the substrate adaptor and the substrate recognition protein.
Results: Tandem affinity purification and LC/MS-MS analysis of the BCR complex led to the identification of 10,225
peptides. After the SEQUEST algorithm and CDART program were used for protein identification and domain prediction,
we discovered a group of Cul3-bound proteins that contain either the LRR or WD40 domain (CLWs). Further biochemical
analysis revealed that the LRR domain-containing CLWs could bind both Cul3 and BTB domain-containing proteins. The
dual binding role for the LRR domain-containing CLWs results in causing the BTB-domain protein to become a substrate
instead of an adaptor.
To further distinguish potential substrates from other components that are part of the BCR ubiquitin ligase complex, we
altered the parameters in the SEQUEST algorithm to select for peptide fragments with a modified lysine residue. This
method not only identifies the potential substrates of the BCR ubiquitin ligase complex, but it also pinpoints the lysine
residue in which the post-translational modification occurs. Interestingly, none of the CLWs were identified by this
method, supporting our hypothesis that CLWs were not potential substrates but rather additional components of the
BCR ubiquitin ligase complex.
Conclusion: Our study identified a new set of Cul3-binding proteins known as CLWs via tandem affinity purification
and LC/MS-MS analysis. Subsequently, our biochemical analysis revealed that some CLWs modify binding of BTB
domain-containing proteins to the complex, causing degradation of the BTB domain-containing protein. As these
CLWs were excluded from our list of substrates, we propose that CLWs serve as unique Cul3 binding proteins that
provide an alternative regulatory mechanism for the complex.
Keywords: Cullin3, Tandem-affinity purification, BTB domain-containing protein, BCR ubiquitin ligase complex,
Mass spectrometry, E3 ubiquitin ligase, Protein purification, Ubiquitin, Ubiquitin ligase
Background
Seven cullins have been identified in mammalian cells
(Cul1, 2, 3, 4A, 4B, 5, and 7); each cullin assembles a
unique set of ubiquitin ligase complexes that catalyze
the formation of polyubiquitin chains to signal the deg-
radation of target proteins by the ubiquitin-dependent
proteolytic pathway [1,2]. The three best-characterized
cullins, Cul1, Cul2, and Cul3, form diverse groups of
ubiquitin ligase complexes with different sets of substrate
recognition modules. For instance, Cul1 forms an Skp1-
Cullin-F-box (SCF) complex that acquires substrate
specificity via two proteins: a Skp1 linker protein and a
substrate adaptor protein containing an F-box domain
[3,4]. Likewise, Cul2 forms an Elongin-Cul2-SOCS-box
(ECS) ubiquitin ligase complex with a ubiquitin-like
protein Elongin B, a Skp1-like linker protein Elongin C and
a substrate adaptor SOCS-box containing protein [5,6].
Conversely, Cul3 forms a BTB-Cul3-Rbx1 (BCR) ubiquitin
ligase complex, in which a BTB domain-containing protein
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serves as both a linker and a substrate adaptor module
[7-9]. It is estimated that more than 200 BTB domain-
containing proteins are expressed in human cells, which
could accommodate a very large number of substrates for
the BCR ubiquitin ligase complex [9].
Previous studies have uncovered new substrates and
unique components of cullin ubiquitin ligase complexes
that suggest new mechanisms for substrate recruitment
[8,10-13]. For example, DDB1 was originally identified
as a substrate adaptor that bound to the N-terminus of
the Cul4A complex using its one β-propeller domain
(BPB), while utilizing the double-β-propeller domain
(BPA-BPC) to provide substrate specificity for the Cul4A
ubiquitin ligase complex [14]. However, a study using
mass spectrometry analysis of the Cul4A complex has
identified a group of WD40 domain-containing proteins
called DWD that can bind to both Cul4A and DDB1.
These DWD proteins were later shown to serve as
additional substrate adaptors for the Cul4A complex
[12,13]. Because of the functional similarity between
DDB1 and BTB domain-containing proteins, this finding
suggests a possibility that the substrate adaptor compo-
nent of the BCR complex may not be limited to BTB
domain-containing proteins.
Here we performed tandem affinity purification (TAP)
followed by Multidimensional Protein Identification Tech-
nology (MudPIT) mass spectrometry to identify new
components of the BCR complex. Several known Cul3-
binding proteins and substrates of the BCR ubiquitin
ligase complex were identified by this method. In an
attempt to rapidly analyze the potential of the BCR
ubiquitin ligase complex from this list of proteins, we
modified the parameters in the SEQUEST algorithm so
that it would recognize the peptide sequence with a
lysine residue that is attached to two glycine residues
on its side chain, which is indicative of a protein that
has been conjugated to ubiquitin or a ubiquitin-like
molecule prior to the tryptic digest.
In addition to many known Cul3 binding proteins and
new substrates, identified by remnants of conjugated
ubiquitin, we have identified two classes of Cul3-bound
proteins with either Leucine-rich repeats (LRR) or a WD40
domain, which will be referred to as CLWs in this study.
Results
Tandem affinity purification of in vivo Cul3 complexes
In this study, a combination of tandem affinity purification
(TAP) and MudPIT mass spectrometry were used to iden-
tify new members of the BCR ubiquitin ligase complex.
To obtain highly purified Cul3 complexes, an expression
cassette encoding a FLAG-TEV-CBP-Cul3 fusion protein
was constructed so that the Cul3 complex could be
purified using anti-FLAG Sepharose beads and calmodulin-
conjugated beads (Figure 1A). The size and expression
levels of the FLAG-TEV-CBP-Cul3 fusion protein were
verified by immunoblotting and probing against either
anti-Cul3 antibody or anti-FLAG antibody (Figure 1B). As
the proportion of neddylated to unneddylated Cul3 was
roughly the same in endogenous Cul3 and overexpressed
Cul3 (Figure 1B, bottom panel, lane 1 and 3), we reasoned
that these purified Cul3 complexes would likely to be part
of a functional BCR ubiquitin ligase complex rather than a
free Cul3 monomer, and thus we proceeded with our
experiment. The Cul3 complexes were purified with
anti-FLAG Sepharose beads and TEV protease cleavage,
where the lack of protein bands in the FLAG immuno-
blot confirmed that the FLAG-tag had been cleaved off
the eluted Cul3 complexes (Figure 1C). Subsequently, the
CBP-Cul3 complexes were purified with calmodulin-
conjugated beads (Figure 1D).
Data analysis on the MS/MS spectra and potential
binding proteins of the BCR ubiquitin ligase complex
Five independent MudPIT experiments were performed
for the Cul3 fusion protein as well as one actin control.
The SEQUEST algorithm was set to match the experi-
mentally obtained mass spectra with theoretical peptides
from the human NCBI nr database, revealing a total of
5,964 peptides from the purified actin control (Table 1, top)
and 10,225 peptides from the purified Cul3 complexes
(Table 1, bottom) [15,16]. Low quality spectra with a mass
error greater than 20 ppm, low Xcorr values (charge 1 < 2,
charge 2 < 2.5, and charge 3 < 3), and other known con-
taminants were discarded. The resulting peptides were
categorized into two groups based on the number of
peptide sequences that match the predicted protein. The
first group of Cul3-binding protein includes proteins that
were either identified by at least two different peptide
sequences or known Cul3-binding proteins that were
identified with at least one peptide sequence in this
study, such as CAND1, Nedd8, KLHL5, Rpn1, and Rpn5
(Additional file 1: Table S1). The second group of potential
Cul3-binding proteins was identified via mass spectra of
one peptide sequence, which required additional manual
validation of the MS/MS spectra as well as further bio-
chemical analysis to confirm their interactions with Cul3
complexes (Additional file 2: Table S2). This list includes
proteins that may be involved in the ubiquitination path-
way, such as pVHL-interacting deubiquitinating enzyme 1,
STIP1 homology and U-box containing protein 1, and
ubiquitin specific proteases.
Identification of leucine-rich repeats and WD40
domain-containing proteins as Cul3 binding proteins
Proteins that corresponded to the identified peptide spectra
were subjected to the domain prediction program CDART
and categorized based on conserved domains [17]. When
compared with the list of proteins identified from purified
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actin complexes, we observed enrichment for proteins that
contain WD40 domains and leucine-rich repeats (LRR) in
the purified Cul3 data set with the percent enrichment
scores of 73.3% of WD40 domain and 90.9% for LRR
domain-containing proteins in the Cul3-bound complex
in contrast to 26.7% of WD40 domain and 9.1% of the
LRR domain-containing protein in the actin-bound
complex (Additional file 3: Tables S3 and Additional
file 4: Table S4). Because domain enrichment maybe
indicative of preferential binding between the BCR
complex and proteins with LRR/WD40 domains, we
chose to further explore the role of these LRR/WD40
domains in the mammalian BCR complex.
The leucine-rich repeats (LRR) and WD40 domain-
containing proteins (CLWs) bind Cul3
Three leucine-rich repeat proteins (LRRs, LRR1, LRR3 and
LRR5 (fibromodulin)) and two WD40 domain-containing
proteins (W14 and W16) were cloned from the list of
32 MudPIT-identified Cul3-bound proteins with LRR
or WD40 domains (CLWs) to verify their binding to
Cul3. The cDNAs were fully sequenced and cloned into
mammalian expression vectors in frame with the HA-tag.
The proteins were co-expressed with FLAG-tagged Cul3
(FLAG-Cul3). Immunoprecipitation assays revealed that
FLAG-Cul3 was able to specifically bind the HA-tagged
CLWs with either the LRR (Figure 2A) or the WD40
domains (Figure 2B), which further confirms the results
from the proteomic analysis.
Cul3 mutants that cannot bind BTB domain-containing
proteins have enhanced binding to LRRs
To clarify how other Cul3 binding proteins affect or
regulate the binding of LRRs to Cul3, we tested a variety
of Cul3 mutants that were unable to bind various Cul3
binding partners. Mutants that could not be neddylated
(K712R) or could not bind RBX1 (F665D) were able to
bind the LRR proteins in an identical fashion to wild
type Cul3 (not shown). Surprisingly, mutants that
could not bind BTB domain-containing proteins (Δ51-
67, Figure 2C) showed enhanced binding to both
LRR1 and LRR5 (Figure 2D). This observation led us
to investigate a possible interaction between LRRs and
BTB domain-containing proteins.
LRRs bind to BTB domain-containing proteins
Based on our observation that removal of the BTB binding
region of Cul3 enhanced LRR binding we hypothesized
(See figure on previous page.)
Figure 1 Tandem affinity purification of 3XFLAG-TEV-CBP-Cul3 complexes. A. Diagram for the tandem affinity purification of the Cul3 binding
proteins. 3XFLAG-TEV-CBP-Cul3 was first affinity purified using anti-FLAG M2 affinity gel resin. Subsequently, the Cul3 complexes were cleaved
off the gel resin by the TEV protease enzyme. The eluted CBP-Cul3 complexes were affinity purified using calmodulin-conjugated beads and
the Cul3 complexes were subsequently subjected to analysis by MudPIT mass spectrometry. B. Untransfected HEK293 cells (lane 1) and HEK293 cells
transfected with either FLAG-tagged Cul3 (lane 2) or FLAG-TEV-CBP-Cul3 (lane 3) were harvested and sonicated in RIPA buffer. Cell lysates were
immunoblotted and probed with anti-FLAG (top panel) and anti-Cul3 antibodies (bottom panel). C. Complexes containing Cul3 were isolated
in the first step of the tandem affinity purification. Cell lysates containing FLAG-TEV-CBP-Cul3 protein were subjected to immunoprecipitation
using anti-FLAG beads (left lane). CBP-Cul3 was released from the beads using the TEV protease (eluted fractions, lane 1). The FLAG beads
were subsequently washed with TEV protease buffer (eluted fractions, lanes 2–4) and calmodulin-binding buffer (eluted fractions, lanes 5–6).
The collected supernatants were immunoblotted and probed with anti-Cul3 antibody (top panel) and anti-FLAG antibody (bottom panel). D.
The CBP-Cul3 complex was isolated in the second step of the tandem affinity purification. Ten milliliters of combined CBP-Cul3 fractions from the first
step of the tandem affinity purification were incubated with calmodulin-conjugated beads, followed by several washes with the calmodulin-binding
buffer and the calmodulin-rinsing buffer. A sample of protein-bound calmodulin beads was collected (left lane). Cul3 complexes were eluted from
the calmodulin beads using the calmodulin-eluting buffer containing EGTA (lane 1–6). The eluted fractions were immunoblotted and probed with
anti-Cul3 antibody. The fractions that contained the most Cul3 were selected for MudPIT analysis. See Additional file 3: Table S3.
Table 1 Summary of TAP tag experiments to find Cul3 and actin-binding proteins
Exp. # # of cells Total protein (mg) TAP yield (mg) Separation MS input (mg) Peptides Peptides </=20 ppm error
Actin-binding proteins bound to 3XFLAG-TEV-CBP-Actin:
1 9.5 × 107 264 64 MudPIT 15 5964 883
Cul3-binding proteins bound to 3XFLAG-TEV-CBP-Cul3:
1 6.9 × 107 192 280 MudPIT 15 4158 562
2 6.9 × 107 192 52 MudPIT 15 1395 234
3 7.5 × 107 208 36 MudPIT 15 1862 393
4 6.5 × 107 180 39 MudPIT 15 1405 276
5 6.5 × 107 180 39 MudPIT 15 1405 117
Total Cul3 bound peptides: 10225 1582
See also Additional file 1: Table S1.
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that they may either have overlapping binding sites on
Cul3 or interact with each other. To test this hypoth-
esis, we examined Ctb73 [18], also called BTBD1 [19,20]
(Figure 3A), which is a BTB domain-containing protein
previously shown to mediate substrate binding to Cul3,
for its ability to bind to LRR1 and LRR5 (Figure 3B). In
both cases, Ctb73 bound specifically to the LRRs. To
further map the regions of interaction, we deleted the
BTB domain on Ctb73. Unexpectedly; this form of Ctb73
showed enhanced binding to the LRRs. We confirmed this
enhanced binding with a different combination of LRRs
and BTB domain-containing protein mutants (Additional
file 1: Figure S1). These results imply that there is a
secondary interaction region outside the BTB domain
that mediates binding between LRRs and BTB domain-
containing proteins.
To further dissect the binding interaction between
Ctb73 and LRRs, we created several Ctb73 deletion mu-
tants, one of which has a deleted region N-terminal to the
BTB domain (Ctb73Δ2-61), which is extremely proline
rich (20%) (Figure 3C). We also examined binding be-
tween LRR5 and the Ctb73 deletion mutants without the
BTB domain, the BACK domain and the Kelch domain.
Though each domain deletion failed to completely disrupt
the binding, we observed slight reduction between the
binding of the Ctb73Δ2-61 mutant and LRRs (Figure 3C,
lane 2). We speculated that the reason we could not
completely eliminate binding between Ctb73 and LRR5
was that they both were able to bind Cul3 and therefore
bridging of Cul3 caused the remaining binding.
Cul3 forms a complex with a BTB/Kelch domain-
containing protein and a LRR domain-containing protein
Based on our observations that LRRs bind to Cul3 and
BTB domain-containing proteins, as well as prior know-
ledge that Cul3 binds BTB domain-containing proteins,
we wanted to determine if the three proteins co-existed
within the same complex. FLAG-Cul3 with a TEV prote-
ase cleavage site (FLAG-TEV-Cul3) was co-expressed
Figure 2 The newly identified Cul3 binding proteins (CLWs) bind
to Cul3 in cells. HEK293 cells were transfected with vectors expressing
FLAG-tagged Cul3 and HA-tagged CLWs. A. Western blot analysis shows
expression and binding of Cul3 and two LRR domain-containing
proteins, LRR1 (left two lanes) and LRR5 (right two lanes). B. Western
blot analysis shows expression and binding of Cul3 and two WD40
domain-containing proteins, W14 (left two lanes) and W16 (right two
lanes). C. Wild type Ctb73 was cotransfected with wild type Cul3 (first
lane), or a Cul3Δ51-67 mutant (second lane) or expressed alone (third
lane). Upper panel shows relative binding between Cul3 and Ctb73, while
lower panel shows the expression levels of Ctb73. D. Immunoprecipitation
assays to detect binding between two different LRR proteins: LRR1 (lane
1–3) and LRR5 (lane 4–6). Wild type Cul3 was expressed in lanes 1 and 4,
while the Cul3Δ51-67 mutant was expressed in lane 2 and 5. Lastly, Cul3
was not transfected in lane 3 and 6, which serves as negative controls for
the immunoprecipitation assays. See also, Additional file 4: Table S4.
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with MYC-Ctb73 and HA-LRR5. FLAG-beads were used
to purify the Cul3 complex, which were subsequently
treated with TEV protease to release the protein complex
from the beads. The resulting soluble proteins were sub-
jected to a second round of immunoprecipitation with
MYC antibody to pull down MYC-Ctb73. The resulting
protein complexes were analyzed by Western blot analysis
to detect the presence of the third protein, HA-LRR5.
Two sequential affinity purifications of FLAG-Cul3 and
MYC-Ctb73 pulled down significant amounts HA-LRR5
only in the presence of all three proteins (Figure 3D, top
panel). These data verify our hypothesis that Cul3, a BTB-
Figure 3 The BTB domain-containing proteins bind LRRs, while the ΔBTB mutant enhances the binding interaction. A. Ctb73 contains
three protein-protein interaction domains; BTB domain, BACK domain and PHR (kelch) domain. B. MYC-Ctb73 was immunoprecipitated and probed
with anti-HA antibodies to detect binding to LRR1 and LRR5 (upper panel). Lower panels show the expression levels of the HA-LRRs in transfected cells.
C. MYC-Ctb73 wild-type or deletion mutants were pulled down by anti-MYC antibody and probed against HA (upper panel) to locate LRR5 binding site
on Ctb73. Relative expression levels of HA-LRR5 are shown in lower panel. D. Two sequential immunoprecipitations were performed on cell lysates
expressing FLAG-TEV-Cul3, MYC-Ctb73 and HA-LRR5. FLAG beads brought down Cul3 complexes that were cleaved off the resin using TEV protease.
The eluted proteins were verified by Western blot for Cul3. Subsequent immunopreciptiation with MYC antibody brought down a protein complex
containing Ctb73. Western blot analysis showed LRR5 binding to the Cul3-Ctb73 complex. Relative protein levels are shown in bottom three panels.
E. Cell lysates co-expressing Cul3, Ctb73 and LRRs were used in the immunoprecipitation of FLAG-Cul3 that pulled down HA-LRR1 and HA-LRR5. In
the same transfection set, immunoprecipitation of FLAG-Cul3 also brought down MYC-Ctb73. Relative expression levels of LRR1, LRR5 and MYC-Ctb73
were verified by Western blotting. See also Additional file 1: Figure S1.
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domain containing protein and an LRR could co-exist
within the same complex.
Because our results in Figures 2 and 3 suggested a poten-
tial for overlapping or co-regulation of binding between
BTB domain-containing proteins and LRRs on Cul3, we
also compared complex formation on wild type Cul3
versus the mutant that cannot bind BTB domain-
containing proteins (FLAG-Cul3Δ51-67). We observed
a slight increase in the binding between the LRRs and
the Cul3 mutant when compared to wild type (Figure 3E
lanes 2 and 4), which further supports a overlapping
binding model.
A B/C-like box sequence mediates LRR binding to Cul3
complexes
As several LRRs are very small and the LRR domain
dominates the coding sequence, we began determining
the regions on the LRRs that mediate interactions with
Cul3 and/or the BTB domain-containing proteins. In
this case, the deletion of LRR domain would not be
informative because the remaining portion would be
short peptides that were unlikely to fold properly. We
could not find any conserved regions outside of the LRR
domains that were shared by the identified LRR domain
containing proteins. Further examination however revealed
a sequence adjacent to the LRR domain that strongly
resembles a B/C box (Figure 4A). To determine if this
sequence may be playing a role in the interaction
between the LRR domain containing proteins and Cul3
complexes, we created I330G C334A mutations in the
putative B/C-like box of the LRR5 (HA-LRR5-B/C)
and tested its binding to Cul3 (Figure 4B) and Ctb73
(Figure 4C). When compared with wild-type LRR5, we
observed that the LRR5-B/C mutant showed enhanced
binding to wild type Cul3 (Figure 4B, lanes 1 and 4).
However, the LRR-B/C interaction with Cul3Δ51-67
mutant that could not bind BTB domain was com-
pletely eliminated, though this form of Cul3 mutant
showed enhanced binding to wild type LRRs (Figure 4B,
lanes 2 and 5). Additionally, the binding between the
LRR5-B/C mutant and various Ctb73 deletion mutants
were examined. We observed that LRR5-B/C mutant
maintained the same binding interaction with wild-type
Ctb73 and most of the deletion mutants (Figure 4C).
However, the binding interaction between the LRR5-B/C
mutant and the Ctb73Δ2-61 was eliminated (Figure 4C,
lane2), indicating that this B/C-like box is the major
mediator of binding the LRR domain-containing protein
to the BTB domain-containing protein. This B/C-like box
binds the N-terminal sequence (residues 2–61) on the
BTB domain containing protein. In addition, the residual
binding between Ctb73Δ2-61 and wild type LRR5 was due
to bridging via Cul3. We speculated that the enhanced
binding of the LRR-B/C-like box mutant to wild type Cul3
was due to the reduced interaction between the LRR-B/C
mutant and a BTB domain-containing protein in the
complex, thus eliminating the interaction we have
previously shown to regulate LRRs binding to Cul3.
Consistent with this model, LRR5-B/C does not show
enhanced binding to the version of Ctb73 that is missing
its BTB domain, unlike wild-type LRR5 (Figure 4D, lane 2
vs. lane 5). A graphical summary of these interactions is
shown in Figure 4E.
FMOD (LRR5) causes FAZF to become degraded
In order to determine the potential cellular role for these
complexes that contain a BTB domain-containing protein,
an LRR domain-containing protein and Cul3, we per-
formed two hybrid screens using LRR5 as bait. After
screening greater than a million clones we identified only
one strong binding partner, FAZF. FAZF is a BTB
domain-containing protein that has been shown to be
important in transcriptional regulation of B-cell differ-
entiation [21]. This was a surprise since we have seen
LRR5 bind several BTB domain-containing proteins, and
the library we used contains many BTB domain-containing
proteins [18]. In order to determine specificity and verify
these two proteins bind in mammalian cells LRR5 was
co-expressed with either FAZF or the highly similar
protein PLZF [22] (Figure 5A). Interestingly, LRR5 bound
FAZF and not PLZF and also appeared to cause a reduction
in expression levels of FAZF (Figure 5A). We therefore felt
that the binding interaction was potentially biologically
significant. FAZF overexpression has been shown to cause
G1 arrest and apoptosis in B cell lines [21], in addition
LRR5 (FMOD) is highly overexpressed in some types of
leukemias [23]. Enforced down regulation of LRR5 in
these leukemias also results in apoptosis [24]. Based on
this observation and on our previous data regarding
the relationship between LRR5 binding Cul3 and BTB
domain-containing proteins, we postulated that LRR5
might be involved in regulating the levels of the BTB
domain-containing protein FAZF. We reasoned that a
complex of all three might convert the BTB domain-
containing protein to a substrate instead of a substrate
adaptor by modulating how it binds to Cul3. Consistent
with the proposed hypothesis, the reduced levels of FAZF
caused by coexpression of both LRR5 and FAZF could
be restored by inhibiting the proteasome with MG-132
(Figure 5B). We then focused on a potential for LRR5
to modulate expression levels of endogenous FAZF using
a well-characterized antibody against FAZF [21]. We
found that high expression of LRR5 dramatically reduced
endogenous levels of FAZF (Figure 5C). As LRR5 levels
were decreased using coexpression of shRNA against
LRR5, the levels of FAZF increase demonstrating an
inverse relationship between expression of LRR5 and
FAZF. An analogous experiment in which LRR1 was
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coexpressed with shRNA against LRR5 showed no change
in endogenous FAZF levels (Figure 5D, note: these cells
do not express detectable LRR5, not shown). From these
data we conclude that LRR5 negatively regulates levels
of endogenous FAZF, similar to the regulation we saw
with coexpression.
A method to characterize potential substrates of the BCR
ubiquitin ligase complex by mass spectrometry
The identification of known substrates of the BCR ubi-
quitin ligase complex, such as Mei1 and GluR1, by our
MudPIT analysis led to the hypothesis that some of
the newly identified Cul3-binding proteins are protein
Figure 4 B/C-like box mediates binding between Cul3 complexes and LRRs. A. Alignment of VHL and Elongin C B/C boxes with putative
B/C-like boxes in three LRRs identified in our study. B. Cul3 binding to wild type LRR5 and LRR5-B/C-like box mutant. Upper blot shows
immunoprecipitation of Cul3 followed by blotting with anti-HA antibody to detect the presence of LRR5 proteins. Lower blot, relative
amounts of LRR5. C. Ctb73 binding LRR5-B/C-like box mutants. Upper blot shows immunoprecipitation of Ctb73 followed by blotting with
anti-HA antibody to detect the presence of LRR5 protein. Lower blots show relative amounts of LRR5 and Ctb73 proteins. D. Binding of
Ctb73 and Ctb73ΔBTB mutants to LRR and LRR5-B/C mutant. Upper blot shows immunoprecipitation of Ctb73 followed by blotting with
anti-HA antibody to detect the presence of LRR5 proteins. Lower blots show relative amounts of LRR5 and Ctb73 proteins. E. Graphical
summary of the interactions between Cul3, a BTB domain-containing protein and a LRR domain-containing protein.
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substrates targeted for ubiquitination by the BCR ubi-
quitin ligase complex. A large number of Cul3-binding
proteins in this study made it impossible to individually
analyze these potential substrates of the BCR ubiquitin
ligase complex. Therefore, we searched for a screening
method that would identify a large number of potential
substrates in a short period of time. We, and others, have
previously observed that Cul3 and protein substrates of
the BCR ubiquitin ligase complex could be co-purified
by an immunoprecipitation assay [12,25], which led us
to speculate that some substrates may remain bound to
the Cul3 complex in their ubiquitinated form. In this
analysis, purified Cul3 complexes were digested with
trypsin, yielding a mixture of ubiquitinated and non-
ubiquitinated precursor peptides that were analyzed by
the mass spectrometer. Trypsin also cleaved conjugated
ubiquitin molecules after the C-terminal lysine 74, leaving
two glycine residues attached to the protein substrate
on the side chain of the ubiquitinated lysine. Therefore,
the mass of a tryptic peptide with a ubiquitinated lysine
residue would also include the mass of two glycine resi-
dues from the C-terminal end of the conjugated ubiquitin,
which would allow us to distinguish these potential
substrates of the BCR ubiquitin ligase complex among
hundreds of Cul3-binding proteins.
In order to identify potential substrates of the BCR
ubiquitin ligase complex, we modified the parameters of
the SEQUEST algorithm with a variable modification on
lysine of 114 Da, which is consistent with a Gly-Gly modi-
fication. This alternative analysis of the mass spectra has
led to the identification of 17 potential substrates that
were each identified by at least two peptide sequences and
spectra with a mass error value of less than 20 ppm and a
high Xcorr value (charge 1 ≥ 2, charge 2 ≥ 2.5, and charge
3 ≥ 3) (Table 2). Approximately 27% of the total potential
Cul3-binding proteins were conjugated with ubiquitin
molecules, only 1.53% of these proteins contain the pre-
dicted spectra that matched the mass spectra of both
ubiquitin-conjugated and unconjugated peptides (Table 2).
Furthermore, the SEQUEST algorithm also distinguishes
Figure 5 LRR5 regulates FAZF abundance. A. LRR5 was co-expressed with either PLZF (lane 2) or FAZF (lane 4). Binding was only seen with
the LRR5/FAZF pair (upper blot, lane 4). Protein levels are shown in lower two blots. B. Coexpression of LRR5 and FAZF results in reduced FAZF
expression (upper blot, lane 1 vs lane 2). Levels of FAZF are restored during co-expression when the proteasome is inhibited by MG-132 (lanes 3
and 4). Relative protein levels are shown in lower blots. C. LRR5 expression reduces levels of endogenous FAZF, upper blot shows LRR5 expression
with increasing amounts of shRNA. Middle blot is endogenous FAZF (arrow). Lower blot is actin to show relative protein loading levels. D. Same
as in C, but instead of co-expression LRR5, LRR1 was used.
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Table 2 Potential ubiquitin-conjugated Cul3-binding proteins and their ubiquitination sites
Protein name Number of
residues
Accession # Domains Peptide
sequence
Ub-sites Charge
state
Mass
error (ppm)
XCorr
value
Exp
L2
Exp
M3
Exp
M4
Exp
M5
Exp
M6
Exp
M7
Cell division/Cell cycle control
Rb1-inducible coiled coil protein 1 1594 NP_055596 No domain LTHLGTAVSVMAK* K201 2 12.4 2.012 1 - - - - -
TFVQK*EQCDFSNSLK K828 2 19.7 2.885 - 1 - - - -
Cytoskeleton
DST protein 258 AAH04912 GAS2 K*SPASKLDK K249 2 15.5 2.055 1 - - - - -
SPASKLDK none 1 18.7 2.136 1 - - - - -
EKFILADGASQGMAAFRPR none 2 16.6 2.693 - 1 - - - -
Filamin B 2591 BAD52434 CH, IG_FLMN ATQTGDASK none 1 18.6 1.584 1 - - - - -
ETTDFKVDTKAAGSGELGVTMK none 2 3.9 3.121 - 1 - - - -
SGCIVNNLAEFTVDPK* K673 2 9.7 2.139 1 - - - - -
Hormone receptor
Thyroid hormone receptor interactor 11 1979 NP_004230 No domain K*VAFDVK*MENEK K670,
K676
2 17.8 2.879 - - 1 1 2 -
K*VAFDVKMENEK* K670,
K681
2 5.4 2.581 1 - - - - -
MQLLQSLQEQK none 2 0.6 2.463 1 - - - - -
Immune system
Lymphocyte antigen 75 1722 NP_002340 FN2, CLECT DGAICYK*PTK K1514 2 6.6 2.182 1 - - - - -
DGAICYKPTK* K1517 2 9.8 2.260 1 - - - - -
Metabolism
Aspartate beta-hydroxylase isoform a 758 NP_004309 Asp-B_Hydr,
TPR, Asp-Arg-Hy
ARYGK*AQCEDDLAEK K381 2 12.1 2.730 - 1 - - - -
ARYGKAQCEDDLAEK* K391 2 3.9 2.338 - 2 - - - -
PKLLNK*FDK K332 2 3.9 2.338 1 - - - - -
Muscle
Long myosin light chain kinase 1914 AAQ02673 S_TKc, FN3,
IGcam
ESK*LDSLEAAAK K284 2 5.0 2.382 1 - - - - -
ESKLDSLEAAAK*SK* K293,
K295
1 19.7 2.338 1 - - - - -
Myosin binding protein C, fast type 1141 NP_004524 FN3, IGcam TSEKK*SDTAGELDFSGLLK* K175,
K185
3 1.4 2.821 1 - - - - -
TSENAIVVVAGNK* K562 2 12.6 2.967 - - - 1 - -
Nesprin-1 8797 AAN60442 CH, SPEC SAREKGER none 1 8.9 1.688 1 - - - - -
WVQYTAGKQTGIEVKDFGK* K212 3 20.0 3.426 - 1 - - - -
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Table 2 Potential ubiquitin-conjugated Cul3-binding proteins and their ubiquitination sites (Continued)
Neuron
Synaptojanin 2A 1288 AAN73051 Syja_N, IPPc SSGKIFKDFHEGAINFGPTYK none 2 0.9 2.005 1 - - - - -
TGMGGK*AGNKGAVGIR K678 2 3.6 2.048 1 - - - - -
Oncoprotein
BRCA2 and CDKN1A interacting protein 322 CAI12093 No domain AGLIQSR none 1 9.2 1.813 1 - - - - -
NCEK*SMVEQLDK K159 1 19.7 1.922 1 - - - - -
Signal transduction
Endothelial differentiation, sphingolipid
G-protein-coupled receptor, 1
382 NP_001391 7tm_1 CPSGDSAGKFK*R K340 2 6.1 2.170 1 - - - - -
HYNYTGK* K34 1 14.8 1.973 1 - - - - -
Triple functional domain
(PTPRF interacting) variant
2202 BAD92991 SPEC, SH3,
RhoGEF, PH_TRIO
AFAAALDER none 2 15.9 3.027 - - 1 - - -
LVNASVAFYK* K1003 2 1.4 2.046 1 - - - - -
Ubiquitination
Cullin3 768 NP_003581 Cullin GVKGLTEQEVETILDK* K414 2 11.9 2.443 1 - - - - -
Unknown function
Chromosome 10 open reading frame 92 876 AAH34223 No domain GRKGSIPR none 1 17.3 1.551 1 - - - - -
ARVQTPAVVADSGKSK none 2 6.7 2.024 1 - - - - -
K*GSIPR K233 1 1.2 1.535 1 - - - - -
KIAA1602 protein 906 AAH33253 No domain EGAGGGSPLR none 2 11.5 2.039 1 - - - - -
SKGLPK* K62 1 3.8 1.931 1 - - - - -
RING finger and CHY zinc finger
domain containing protein 1 variant
263 BAD92309 zf_CHY DKK*QYHCENCGICR K65 2 10.2 2.581 - 1 - - - -
GYRCPLCMHSALDMTR none 2 1.1 2.126 1 - - - - -
PYK*CMHCEK*VFR K306,
K312
2 16.4 2.036 1 - - - - -
Legend:
*Charge state represents the charge state of the precursor peptide ion.
*Mass error (ppm; parts per million) represents the calculated mass difference between the mass of theoretical precursor peptide and the mass of the experimental precursor peptide.
*Xcorr value represents the calculated value of the accuracy between the peaks of the theoretical spectra and the experimental spectra.
*Ub-sites represents the position of the ubiquitin-conjugated lysine residues in a given protein.
*Number of the peptides based on the corresponding mass spectra from each mass spectrometry experiment shown in Table 1 (L = long gradient; M =MudPIT).
The ubiquitinated lysine residues are marked by an asterisk (*). See also Additional file 1: Figure S2.
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the position of the modified lysine residues within each
precursor peptide. Therefore, this MudPIT approach not
only identifies potential substrates of the BCR ubiquitin
ligase complex in less time than traditional biochemical
assays, it also predicts the ubiquitin conjugation sites on
each potential substrate that would otherwise require
many mutational analyses to obtain. Based on our ana-
lysis, we observed that none of the CLW proteins were
identified by this method, thus further supporting our
hypothesis that they are not substrates for the ubiquitina-
tion process, but rather part of the BCR ubiquitin ligase
complex.
To verify this algorithm for predicting potentially real
ubiquitination sites, we mutated the predicted site on
Cul3 (K414R) based on our MudPIT data indicating that
the K414 residue on Cul3 contains a ubiquitination site
based on the extra mass that is equivalent to two glycine
residues (Table 2). Biochemical analysis demonstrated
that K414 was a genuine ubiquitination site for Cul3 in
cells (Additional file 1: Figure S2).
Discussion
Since the discovery of Cul3, the characterization of the
BCR ubiquitin ligase has progressed rapidly and has
resulted in the identification of protein substrates and
novel subunits of the BCR ubiquitin ligase complex
[18,26-30]. In this study, a MudPIT approach was chosen
for the analysis of Cul3 complexes to identify novel proteins
that could be part of the Cul3-dependent ubiquitination
pathway. As a result, we have identified new members of
the Cul3 complex using two different approaches: (1) the
identification of potential substrates of the BCR ubiquitin
ligase complex and their ubiquitination sites by altering
the criteria in the SEQUEST algorithm to identify Cul3-
bound ubiquitin-conjugated proteins, and (2) the analysis
of proteins with conserved domains among the MudPIT-
identified Cul3-binding proteins that resulted in the
characterization of previously unidentified Cul3-bound
proteins containing either LRR domains or WD40 domains
(CLWs).
Based on our chemical analysis, we propose that the
LRR domain-containing proteins (LRRs) function to modify
the binding of the BTB domain containing protein to Cul3
such that the BTB domain containing protein becomes a
substrate. LRRs bind to Cul3 not only via the BTB domain-
containing protein, but also through other regions of the
Cul3 complex, as the Cul3 mutant that cannot bind BTB
domain-containing proteins (Cul3Δ51-67) can still bind
LRRs. In addition, these Cul3-bound LRRs were not ubi-
quitinated, suggesting they are unlikely to be substrates
of the BCR ubiquitin ligase complex. This conclusion is
further supported by the fact that substrates are unlikely
to share a domain (such as an LRR domain) because the
mechanism of substrate recognition is usually based on
short sequences [31,32].
LRR domain-containing proteins regulate binding
between Cul3 and BTB-domain containing proteins
We discovered that the LRR domain-containing proteins
modulated the binding of the BTB domain-containing
proteins binding to Cul3 such that they became substrates
instead of substrate adaptors. We found that a region on
the BTB domain-containing protein just N-terminal to the
BTB domain appears to be mediating the interaction with
LRR domain-containing proteins. This region on Ctb73 is
extremely proline-rich; it is interesting to note that other
BTB domain proteins that have been shown to bind Cul3
also have similar proline rich regions in their N-terminus,
like actinfilin, BTBD2, and FAZF (PLZF does not have this
region and does not bind LRR5). Thus, this region may
play a role in a number of other BTB-domain protein/
LRR-domain protein interactions. In addition the LRR
domain-containing proteins contain a sequence that re-
sembles a B/C box that mediates binding to the BTB
domain-containing proteins.
Based on the identification of the WD40 domain in
substrate adaptor subunits of the Cul4 complex, we first
proposed that our MudPIT-identified WD40 domain-
containing proteins also behave similarly in the Cul3
complex. However, mutational analysis revealed that the
interaction site for the WD40 domain-containing proteins
lies within the conserved cullin domain in C-terminal
region of Cul3, suggesting that their binding interactions
did not resemble those found on the LRRs (not shown).
Therefore, the WD40 domain-containing proteins may
function in a completely different way than the LRRs.
Potential substrates of the BCR ubiquitin ligase complex
identified by a method that involves an altered SEQUEST
algorithm
To distinguish novel Cul3-binding proteins from poten-
tial substrates of the BCR ubiquitin ligase complex, we
adjusted the parameters in the SEQUEST algorithm to
recognize the ubiquitin-modified lysine residue in the
peptide spectra. Manual validation of the mass spectra
revealed that the altered SEQUEST parameters could be
used to identify ubiquitinated precursor peptides that
are derived from the ubiquitin-conjugated proteins. This
technique for the identification of ubiquitin-conjugated
proteins using MudPIT mass spectrometry is an approach
that can be applied to the analysis of ubiquitinated pro-
teins bound to other ubiquitin ligase complexes. Using
this technique, our list of MudPIT-identified Cul3-binding
proteins also includes GluR-1, Mei1 and p60/katanin
(Additional file 1: Table S1), which are known substrates
of the BCR ubiquitin ligase complex [18,33,34], further
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supporting the validity of this method for substrate
identification.
Cul3 mediated the ubiquitination of lysine residues on its
substrates based on the proximity of its location rather
than selecting residues based on specific sequences
In this analysis, we have identified the position of lysine
residues on which ubiquitin molecules were conjugated to
target proteins, as well as the minimum number of ubiqui-
tination sites that are found on each potential substrate.
As a heterogeneous population of both ubiquitinated and
non-ubiquitinated lysine residues were observed in identi-
cal tryptic peptides of Cul3-binding proteins (Table 2), we
believe that the BCR ubiquitin ligase complex exhibits
some flexibility in the selection of its ubiquitin conjuga-
tion site. Furthermore, a significant number of potential
substrates also contain more than one ubiquitination site.
Additionally, lysine residues that are within 10 residues of
each other are often ubiquitinated at both positions. These
findings suggest that the mechanism of ubiquitination
by the BCR complex is not based on a specific protein
sequence adjacent to the ubiquitinated lysine residue,
but may be approximated by the distance of the bound
substrate from the ubiquitin-conjugating enzyme. This
hypothesis is partly based on a study, which indicates
that the initial selection for the ubiquitination site on
protein substrates is determined by a tertiary complex
of E2-E3-substrate [35].
Model of the BCRLRR complexes
The SCF model for cullin-based E3 ligase stated that
the cullin provides a scaffold to assemble a ubiquitin-
conjugating enzyme (E2), Skp1 and an F-box containing
protein. The F-box containing protein recognizes substrates
and recruits them to the E3 complex (Figure 6A). Previous
models of the BCR ubiquitin ligase complex proposed that
a BTB domain-containing protein serves the combined
functions of both Skp1 and the F-box protein by binding to
Cul3 via its BTB domain and using its secondary protein-
protein interacting domain to target its bound substrates
for ubiquitination (Figure 6B). This model is supported by
the identification of substrates of the Cul3 ubiquitin ligase
complex and their adaptor proteins, such as Nrf2 and
Keap1, GluR1 and actinfillin, Dishevelled and KLHL12,
Aurora B and KLHL11/KLHL9 and p60/katanin and
KLHDC5 [18,36-39]. In this report, we have identified an
additional group of Cul3-binding proteins that contain
either LRR domains or WD40 domains. Incidentally, these
some of these LRR domain-containing proteins also
interact with the BTB domain-containing proteins. We
propose that the B/C-like box domain on the LRRs and a
unique, proline rich domain on the BTB domain contain-
ing protein Ctb73 is responsible for the binding between
the BTB domain-containing protein, the LRRs and Cul3.
This binding causes the BTB domain-containing protein
to become a substrate, possibly by changing how it binds
to Cul3 (Figure 6C).
Conclusions
In this report, we have identified an additional group of
Cul3-binding proteins that contain either LRR domains or
WD40 domains. We propose that the B/C-like box domain
on the LRR domain-containing proteins and a unique, pro-
line rich domain on the BTB domain containing protein
Ctb73 is responsible for the binding between the BTB
domain-containing protein, the LRRs and Cul3. However,
the binding interaction may be more complex because
deletion of the BTB domain resulted in enhanced LRR
binding to Cul3. These observations led us to further
investigate these interactions. We found that one of these
LRR domain-containing proteins, LRR5/FMOD, causes a
BTB domain-containing protein, FAZF, to become a sub-
strate for the BCR complex. Possibly, this mechanism is
a way for BTB domain proteins to be removed from
substrates. There are several know examples of cullin
based E3 ligases degrading their substrate adaptors
[40,41], thus we suggest that this may be a general
theme for the function of these novel Cul3 binding pro-
teins. The selective specificity of LRR5 for FAZF and
not the highly homologous protein PLZF is intriguing
and may indicate specificity for LRR domain-containing
proteins binding BTB domain-containing proteins. Add-
itional biochemical analyses will lead to a more thorough
understanding of this novel regulatory mechanism.
Figure 6 A proposed novel regulatory model for the Cul3
complex. A. A schematic diagram of the SCF complex demonstrates
that the N-terminal domain of Cul1 is bound to Skp1 protein and a
substrate adaptor F-box-containing protein. B. The current model of
the BCR complex proposed that a BTB domain-containing protein
utilizes other protein-protein interacting domains to bind its protein
substrates. C. A proposed model for an alternative BCR ubiquitin ligase
complex. In this case, we propose that the LRRs bind to Cul3 as well as
to a unique region on the BTB domain-containing protein via a B/C-like
box. This binding serves to change the binding position of the BTB
domain-containing protein on Cul3 causing it to be a substrate instead
of a substrate adaptor protein.
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Methods
Plasmids
Full-length cDNA sequences of Cul3, BTBs, and CLWs
were cloned from a human testis cDNA library and
inserted in-frame into the 3XFLAG-24 (Sigma-Aldrich),
CS2 +MT, and CS2 +HA vectors, respectively. All clones
were fully sequenced. Mutations in the Cul3 protein were
made using the QuikChange site-directed mutagenesis kit
(Stratagene). All plasmids were sequenced after muta-
genesis. Expression plasmids for MudPIT analysis were
constructed by cloning the full-length Cul3 sequence into
the 3XFLAGNEO-26 plasmid (Sigma-Aldrich) in-frame
with the FLAG tag. A TEV recognition sequence and a
calmodulin-binding protein sequence were inserted
in-frame between the 3XFLAG epitope and the Cul3
sequence, creating the 3XFLAG-TEV-CBP-Cul3 plasmid
that was used for tandem affinity purification. As a control,
a 3XFLAG-TEV-CBP-actin plasmid was created by cloning
the full-length actin sequence from a human testis cDNA
library and inserting it in-frame into the 3XFLAG-TEV-
CBP plasmid.
Cell culture and protein expression
HEK293 cell lines were maintained in DMEM media
supplemented with 10% fetal bovine serum (FBS). For
transient protein expression, HEK293 cells were transfected
with either 3XFLAG-TEV-CBP-Cul3 or 3XFLAG-TEV-
CBP-actin plasmids as described previously [42].
Two-hybrid screening
pGildaLRR5 (FMOD) was screened using the Matchmaker
LexA two hybrid system (Clontech). A human testis library
was used and 2.7 million clones were screened. The only
interacting clone identified was FAZF.
Immunoblotting, immunoprecipitation and
immunofluorescence
Transfected HEK293 cells were harvested in 2.7 mM
EDTA in phosphate-buffered saline and cell lysates were
prepared by sonication for 10 seconds in radioimmuno-
precipitation assay (RIPA) buffer (1% NP-40, 1% sodium
deoxycholate, 0.1% SDS, 150 mM NaCl, 0.01 M sodium
phosphate buffer pH 7.2 and 2 mM EDTA). For immuno-
precipitation assays, the clarified lysates were incubated
with primary antibody, followed by protein A-Sepharose
beads for 1 hr each at 4°C. Beads were spun down and
washed twice with RIPA buffer. Protein samples were
separated by electrophoresis on 10% polyacrylamide gels,
transferred to PVDF membranes, and incubated overnight
in primary antibodies. Proteins were visualized using en-
hanced chemiluminescence followed by digital acquisition
using an AlphaInnotech Fluorochem SP system. The
following antibodies were used in these experiments:
anti-FLAG M2 monoclonal antibody (Sigma-Aldrich),
anti-actin polyclonal antibody (Sigma-Aldrich), anti-HA
monoclonal antibody (Covance), anti-MYC sc-789 poly-
clonal antibody (Santa Cruz Biotechnology), and anti-Cul3
antibody which has been previously described [43]. The
anti-FAZF antibody was a kind gift of Dr. Maureen
Hoatlin (OHSU). Immunofluorescence was performed
as previously described [18].
FLAG immunoprecipitation and TEV protease cleavage
Clarified cell lysates were incubated with anti-FLAG M2
agarose slurry (Sigma-Aldrich) at 4°C for 1 hour. The
protein-bound beads were washed twice in RIPA buffer
and three times in tobacco etch virus (TEV) buffer
(10 mM HEPES-KOH pH 8.0, 150 mM NaCl, 0.1% NP-
40, 0.5 mM EDTA and 1 mM DTT). The FLAG beads
were then incubated with the AcTEV protease enzyme
(Life Technologies) in TEV buffer overnight at 4°C with
constant agitation. After TEV cleavage was complete, the
supernatant containing Cul3 complexes was collected
and the FLAG beads were washed three times with TEV
protease buffer and twice with calmodulin-binding buffer
(10 mM 2-mercaptoethanol, 10 mM HEPES-KOH pH 8.0,
150 mM NaCl, 1 mM MgOAc, 1 mM Imidazole, 0.1%
NP-40, and 2 mM CaCl2) to recover the Cul3 complexes
that were cleaved but remained bound to the beads. A
sample of FLAG beads prior to TEV cleavage and protein
samples from each eluted fraction were immunoblotted
and probed with the appropriate antibodies to determine
the efficiency of TEV cleavage and to estimate the protein
yield for the next purification step.
Purification with calmodulin-conjugated beads
Collected protein samples from the FLAG immunoprecipi-
tation and the TEV protease cleavage were supplemented
with 1 M CaCl2 solution at a 25:1 ratio, followed by incuba-
tion with Calmodulin Sepharose™ 4B beads (Amersham
Biosciences) for 90 minutes at 4°C. The beads were spun
down at 750 × g and washed three times with the calmodu-
lin-binding buffer and twice with the calmodulin-rinsing
buffer (50 mM NH4HCO3 pH 8.0, 75 mM NaCl, 1 mM
MgOAc, 1 mM imidazole, and 2 mM CaCl2). The bound
protein complexes were then eluted from the calmodulin
beads using calmodulin-eluting buffer (50 mM ammonium
bicarbonate, pH 8.0 and 25 mM EGTA) and collected in
separate fractions. A sample of protein-bound calmodulin
beads and protein samples of each eluted fraction were
immunoblotted and probed with the appropriate antibodies
to estimate the relative protein yield of each eluted fraction.
The fractions with the most amount of protein were se-
lected for further analysis using MudPIT techonology.
Trypsin digestion and peptide desalting
An equal volume of 8 M urea, pH 8.3, was added to the
eluants from the calmodulin bead purification and the
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mixture was denatured at 95°C for 5 minutes. After the
mixture had cooled to room temperature, trypsin (Pro-
mega) was added to purified proteins in a 1:40 w/w ratio
and the mixture was incubated overnight at 37°C. Once
the digestion was complete, the peptide mixture was
diluted with 0.1% acetic acid, adjusted to pH 3, and then
loaded onto a C18 reverse phase peptide macrotrap cart-
ridge (Michrom Bioresources) that had been equilibrated
with 0.1% acetic acid. The cartridge with the bound protein
was washed twice with 0.1% acetic acid and the peptides
were eluted with 70% acetonitrile in 0.1% acetic acid. The
peptide mixture was dried using a SAVANT SC110A
SpeedVac centrifuge with an RVT400 refrigerated vapor
trap (Thermo Electron Corp.) and stored at −80°C.
Strong cation exchange chromatography
The dried peptides were reconstituted in 0.1% acetic acid
to a concentration of 0.5 mg/ml. They were subsequently
loaded onto a strong cation capillary column (home-
packed on a pressure bomb) with an inner diameter of
247.0 μm (Polymicro technology), 20 cm in length, and
fritted by M-520 (Upchurch) containing polysulfoethyl
A™ bulk material of 5 μm diameter and 300 Å pore size
(The Nest Group, Inc.). The samples were eluted with a
12-step salt gradient between buffer C (30% aceto-
nitrile, 5 mM phosphate buffer pH 3) and buffer D
(30% acetonitrile, 5 mM phosphate buffer pH 3, and
500 mM ammonium acetate) with 0.01 ml/min flow
rate for 10 minutes in each gradient step. Each solution
step consists of a different ratio of buffer C to buffer D
(C/D): step 1 = 100/0, step 2 = 98/2, step 3 = 96/4, step
4 = 94/6, step 5 = 92/8, step 6 = 90/10, step 7 = 88/12, step
8 = 86/14, step 9 = 84/16, step 10 = 80/20, step 11 = 50/50,
and step 12 = 0/100. The eluted peptides from each salt
gradient step were collected separately, dried and stored
at −80°C until the next step.
On-line reverse phase column and tandem mass
spectrometry
In preparation for analysis by mass spectrometry, the
dried peptide samples from each salt step fraction were
reconstituted in 0.1% acetic acid. The peptides were loaded
onto a pre-column (360 μm outer diameter × 75 μm inner
diameter) containing 2 cm of 5 μm Monitor C18 resin
(Column Engineering). They were then eluted into the
mass spectrometer (LTQ-FTICR, Thermo Electron Corp.)
through an analytical column (360 μm outer diameter ×
75 μm inner diameter fused silica packed with 12 cm of
5 μm Monitor C18 particles with an integrated ESI emitter
tip having a 4 μm opening fritted with 3 μm silica particles;
Bangs Labs, Fishers, IN) by using a linear HPLC gradient
ranging from 0-70% acetonitrile over 30 minutes using
buffer A (0.1 M acetic acid) and buffer B (0.1 M acetic
acid in acetonitrile) with peak parting. The eluted
peptides were then processed by an LTQ-FTICR mass
spectrometer (data-dependent scanning with 1 MS scan
followed by 5 MS/MS scans). MS/MS spectra were gener-
ated and automatically searched against the human NCBI
non-redundant protein database using the SEQUEST al-
gorithm provided with Bioworks 3.2 SR (Thermo Electron
Corp.). The list of predicted proteins was imported into
a custom-made FileMaker Pro relational database for
data analysis.
Data analysis and domain prediction
MS/MS spectra with mass error of less than 20 ppm and
high Xcorr value (charge 1 ≥ 2, charge 2 ≥ 2.5, and charge
3 ≥ 3) were chosen for further analysis. The exact pre-
dicted peptide sequences were searched against sequences
in the NCBI protein-protein database to uncover potential
Cul3-binding proteins [44]. All corresponding protein
sequences were then scanned for predicted domains
with the NCBI conserved domain architecture retrieval
tool (CDART) [45]. MudPIT mass spectrometry was also
performed on tandem affinity purified actin complexes to
eliminate proteins that may be mistaken for binding part-
ners. These may be contaminants from the purification
that bind non-specifically to the CBP tag or to the surface
of large globular proteins, such as actin. Predicted protein
candidates that were identified in both the actin and
the Cul3 complexes were regarded as false positives
and removed from the list of potential Cul3-binding
proteins. The remaining proteins were then categorized
based on their conserved domains and their roles in
cellular pathways.
Availability of supporting data
The data sets supporting the results of this article are
included within the article (and its additional supple-
mental files).
Additional files
Additional file 1: Table S1. Potential Cul3-binding proteins that were
identified by MudPIT.
Additional file 2: Table S2. Potential Cul3-binding proteins that were
identified by one peptide sequence from MudPIT analysis.
Additional file 3: Table S3. Summary of conserved domains of potential
Cul3 and actin-binding proteins. Figure S1. LRR3 binds Ctb62. HA-tagged
LRR3 was transfected into HEK293 cells, either alone (third lane) or with
MYC-tagged Ctb62 (first lane) or with MYC-tagged Ctb62 deleted for its BTB
domain. Lower gel shows an immunoblot of levels of expression of LRR3 and
the upper blot shows binding of LRR3 to Ctb62 by immunoprecipitating
Ctb62 followed by an immunoblot for LRR3. Figure S2. Cul3 is ubiquitinated
at the lysine 414 residue. HEK293 cells were transfected with vectors
expressing wild-type Cul3, Cul3K414R mutant, and HA-tagged ubiquitin.
Lysates were prepared, checked for protein expression (bottom), and
immunoprecipitated with anti-HA antibody. The precipitates were separated
by SDS-PAGE and analyzed by immunoblot for Cul3.
Additional file 4: Table S4. Summary of proteins that contain conserved
domains of interest from MudPIT-identified Cul3-binding proteins.
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rich repeat; Mei1: Meiosis inhibitor 1; MudPIT: Multidimensional Protein
Identification Technology; Nedd8: Neural precursor cell expressed; Rbx1:
RING-box protein 1; Rpn: Ribophorin; SCF: Skp1-Cullin-F-box; Skp1: S-phase
kinase-associated protein 1; Skp2: S-phase kinase-associated protein 2, SOCS,
suppressors of cytokine signaling; STIP1: Stress-induced-phosphoprotein 1;
TAP: Tandem affinity purification, TEV, Tobacco etch virus.
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